These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 22538300

  • 21. Biphasic and regionally-restricted chemokine expression in the central nervous system in the Theiler's virus model of multiple sclerosis.
    Murray PD, Krivacic K, Chernosky A, Wei T, Ransohoff RM, Rodriguez M.
    J Neurovirol; 2000 May; 6 Suppl 1():S44-52. PubMed ID: 10871765
    [Abstract] [Full Text] [Related]

  • 22. Contrasting roles for axonal degeneration in an autoimmune versus viral model of multiple sclerosis: When can axonal injury be beneficial?
    Tsunoda I, Tanaka T, Terry EJ, Fujinami RS.
    Am J Pathol; 2007 Jan; 170(1):214-26. PubMed ID: 17200195
    [Abstract] [Full Text] [Related]

  • 23. 5-Fluorouracil and levamisole exacerbate demyelination in susceptible mice infected with Theiler's virus.
    Lucchinetti CF, Kimmel DW, Pavelko K, Rodriguez M.
    Exp Neurol; 1997 Sep; 147(1):123-9. PubMed ID: 9294409
    [Abstract] [Full Text] [Related]

  • 24. CCR2 regulates development of Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Bennett JL, Elhofy A, Charo I, Miller SD, Dal Canto MC, Karpus WJ.
    Viral Immunol; 2007 Sep; 20(1):19-33. PubMed ID: 17425418
    [Abstract] [Full Text] [Related]

  • 25. Potential role of CD4+ T cell-mediated apoptosis of activated astrocytes in Theiler's virus-induced demyelination.
    Palma JP, Yauch RL, Lang S, Kim BS.
    J Immunol; 1999 Jun 01; 162(11):6543-51. PubMed ID: 10352270
    [Abstract] [Full Text] [Related]

  • 26. Restraint stress facilitates systemic dissemination of Theiler's virus and alters its pathogenecity.
    Mi W, Young CR, Storts RW, Steelman AJ, Meagher MW, Welsh CJ.
    Microb Pathog; 2006 Jun 01; 41(4-5):133-43. PubMed ID: 16949789
    [Abstract] [Full Text] [Related]

  • 27. Release of myelin basic protein-degrading proteolytic activity from microglia and macrophages after infection with Theiler's murine encephalomyelitis virus: comparison between susceptible and resistant mice.
    Liuzzi GM, Riccio P, Dal Canto MC.
    J Neuroimmunol; 1995 Oct 01; 62(1):91-102. PubMed ID: 7499498
    [Abstract] [Full Text] [Related]

  • 28. Limited remyelination in Theiler's murine encephalomyelitis due to insufficient oligodendroglial differentiation of nerve/glial antigen 2 (NG2)-positive putative oligodendroglial progenitor cells.
    Ulrich R, Seeliger F, Kreutzer M, Germann PG, Baumgärtner W.
    Neuropathol Appl Neurobiol; 2008 Dec 01; 34(6):603-20. PubMed ID: 18466224
    [Abstract] [Full Text] [Related]

  • 29. Beneficial and detrimental impact of transplanted canine adipose-derived stem cells in a virus-induced demyelinating mouse model.
    Hansmann F, Jungwirth N, Zhang N, Skripuletz T, Stein VM, Tipold A, Stangel M, Baumgärtner W.
    Vet Immunol Immunopathol; 2018 Aug 01; 202():130-140. PubMed ID: 30078587
    [Abstract] [Full Text] [Related]

  • 30. Ets-1 represents a pivotal transcription factor for viral clearance, inflammation, and demyelination in a mouse model of multiple sclerosis.
    Gerhauser I, Alldinger S, Baumgärtner W.
    J Neuroimmunol; 2007 Aug 01; 188(1-2):86-94. PubMed ID: 17599467
    [Abstract] [Full Text] [Related]

  • 31. Inhibition of Theiler's virus-mediated demyelination by peripheral immune tolerance induction.
    Karpus WJ, Pope JG, Peterson JD, Dal Canto MC, Miller SD.
    J Immunol; 1995 Jul 15; 155(2):947-57. PubMed ID: 7608570
    [Abstract] [Full Text] [Related]

  • 32. Double-edged effects of tamoxifen-in-oil-gavage on an infectious murine model for multiple sclerosis.
    Hülskötter K, Jin W, Allnoch L, Hansmann F, Schmidtke D, Rohn K, Flügel A, Lühder F, Baumgärtner W, Herder V.
    Brain Pathol; 2021 Nov 15; 31(6):e12994. PubMed ID: 34137105
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Injection of the sciatic nerve with TMEV: a new model for peripheral nerve demyelination.
    Drescher KM, Tracy SM.
    Virology; 2007 Mar 01; 359(1):233-42. PubMed ID: 17028060
    [Abstract] [Full Text] [Related]

  • 35. Viral models of multiple sclerosis: neurodegeneration and demyelination in mice infected with Theiler's virus.
    Mecha M, Carrillo-Salinas FJ, Mestre L, Feliú A, Guaza C.
    Prog Neurobiol; 2013 Mar 01; 101-102():46-64. PubMed ID: 23201558
    [Abstract] [Full Text] [Related]

  • 36. A Theiler's virus alternatively initiated protein inhibits the generation of H-2K-restricted virus-specific cytotoxicity.
    Lin X, Roos RP, Pease LR, Wettstein P, Rodriguez M.
    J Immunol; 1999 Jan 01; 162(1):17-24. PubMed ID: 9886365
    [Abstract] [Full Text] [Related]

  • 37. Innate immune CD11b+Gr-1+ cells, suppressor cells, affect the immune response during Theiler's virus-induced demyelinating disease.
    Bowen JL, Olson JK.
    J Immunol; 2009 Dec 01; 183(11):6971-80. PubMed ID: 19890055
    [Abstract] [Full Text] [Related]

  • 38. Recombinant human IL-6 suppresses demyelination in a viral model of multiple sclerosis.
    Rodriguez M, Pavelko KD, McKinney CW, Leibowitz JL.
    J Immunol; 1994 Oct 15; 153(8):3811-21. PubMed ID: 7930598
    [Abstract] [Full Text] [Related]

  • 39. Anticapsid immunity level, not viral persistence level, correlates with the progression of Theiler's virus-induced demyelinating disease in viral P1-transgenic mice.
    Myoung J, Bahk YY, Kang HS, Dal Canto MC, Kim BS.
    J Virol; 2008 Jun 15; 82(11):5606-17. PubMed ID: 18353953
    [Abstract] [Full Text] [Related]

  • 40. [Theiler's virus encephalomyelitis infection as a model for multiple sclerosis: cytokines and pathogenic mechanisms].
    Molina-Holgado E, Areválo-Martín A, Vela JM, Guaza C.
    Rev Neurol; 2008 Jun 15; 35(10):973-8. PubMed ID: 12436402
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.